Literature DB >> 21454309

Anti-synthetase syndrome positive for anti-isoleucyl-tRNA synthetase antibodies: an unusual case overlapping with systemic sclerosis and Sjogren's syndrome.

Baptiste Hervier, Marc Lambert, Eric Hachulla, Lucile Musset, Olivier Benveniste, Jean-Charles Piette, Zahir Amoura, Nathalie Costedoat-Chalumeau.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21454309     DOI: 10.1093/rheumatology/ker132

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  5 in total

Review 1.  Clinical heterogeneity and outcomes of antisynthetase syndrome.

Authors:  Baptiste Hervier; Olivier Benveniste
Journal:  Curr Rheumatol Rep       Date:  2013-08       Impact factor: 4.592

2.  Severe digital ischemia as an unrecognized manifestation in patients with antisynthetase autoantibodies: Case series and systematic literature review.

Authors:  Akira Yoshida; Takahisa Gono; Yuka Okazaki; Yuichiro Shirai; Mitsuhiro Takeno; Masataka Kuwana
Journal:  J Scleroderma Relat Disord       Date:  2022-05-01

3.  Prognostic factors in a cohort of antisynthetase syndrome (ASS): serologic profile is associated with mortality in patients with interstitial lung disease (ILD).

Authors:  Jorge Rojas-Serrano; Denisse Herrera-Bringas; Mayra Mejía; Hermes Rivero; Heidegger Mateos-Toledo; José E Figueroa
Journal:  Clin Rheumatol       Date:  2015-07-30       Impact factor: 2.980

4.  Organizing pneumonia as the first manifestation of anti-synthetase syndrome.

Authors:  S M Thanuja Nilushi Priyangika; W G S G Karunarathna; Isurujith Liyanage; Methsala Gunawardana; Sumeda Udumalgala; Chamith Rosa; Aruna Kulatunga
Journal:  BMC Res Notes       Date:  2016-06-02

5.  Overlap syndromes in systemic sclerosis.

Authors:  Ewa Wielosz; Maria Majdan; Magdalena Dryglewska; Bożena Targońska-Stępniak
Journal:  Postepy Dermatol Alergol       Date:  2018-06-18       Impact factor: 1.837

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.